SI2114951T1 - Novi zaviralci fosfodiesteraze - Google Patents
Novi zaviralci fosfodiesterazeInfo
- Publication number
- SI2114951T1 SI2114951T1 SI200831224T SI200831224T SI2114951T1 SI 2114951 T1 SI2114951 T1 SI 2114951T1 SI 200831224 T SI200831224 T SI 200831224T SI 200831224 T SI200831224 T SI 200831224T SI 2114951 T1 SI2114951 T1 SI 2114951T1
- Authority
- SI
- Slovenia
- Prior art keywords
- phosphodiesterase inhibitors
- novel phosphodiesterase
- novel
- inhibitors
- phosphodiesterase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90384907P | 2007-02-28 | 2007-02-28 | |
| US94684907P | 2007-06-28 | 2007-06-28 | |
| EP08706922.5A EP2114951B9 (en) | 2007-02-28 | 2008-02-26 | Novel phosphodiesterase inhibitors |
| PCT/DK2008/000080 WO2008104175A2 (en) | 2007-02-28 | 2008-02-26 | Novel phosphodiesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2114951T1 true SI2114951T1 (sl) | 2014-08-29 |
Family
ID=39415336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200831224T SI2114951T1 (sl) | 2007-02-28 | 2008-02-26 | Novi zaviralci fosfodiesteraze |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8338431B2 (sl) |
| EP (1) | EP2114951B9 (sl) |
| JP (1) | JP5501770B2 (sl) |
| KR (1) | KR101571654B1 (sl) |
| AU (1) | AU2008221121B2 (sl) |
| BR (1) | BRPI0807749B8 (sl) |
| CA (1) | CA2676933C (sl) |
| CY (1) | CY1115227T1 (sl) |
| DK (1) | DK2114951T3 (sl) |
| ES (1) | ES2478670T3 (sl) |
| HK (1) | HK1138262A1 (sl) |
| HR (1) | HRP20140585T1 (sl) |
| IL (1) | IL200153A (sl) |
| MX (1) | MX2009009238A (sl) |
| MY (1) | MY150075A (sl) |
| NZ (1) | NZ578804A (sl) |
| PL (1) | PL2114951T3 (sl) |
| PT (1) | PT2114951E (sl) |
| RS (1) | RS53407B (sl) |
| RU (1) | RU2495043C2 (sl) |
| SI (1) | SI2114951T1 (sl) |
| WO (1) | WO2008104175A2 (sl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012007225A (es) | 2009-12-22 | 2012-07-30 | Leo Pharma As | Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d. |
| JP5873439B2 (ja) | 2009-12-22 | 2016-03-01 | レオ ファーマ アクティーゼルスカブ | ビタミンｄ類似体および溶媒と界面活性剤の混合物を含む皮膚組成物 |
| AU2010335655B2 (en) | 2009-12-22 | 2015-03-05 | Leo Pharma A/S | Calcipotriol monohydrate nanocrystals |
| HUE044301T2 (hu) * | 2010-06-24 | 2019-10-28 | Leo Pharma As | Benzodioxol-származékok, mint foszfodiészteráz inhibitorok |
| US20160022681A1 (en) * | 2012-02-14 | 2016-01-28 | University Of Rochester | Methods of increasing lymphatic transport |
| BR112014029642A2 (pt) * | 2012-06-04 | 2017-06-27 | Chiesi Farm Spa | composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit |
| EP2925364A1 (en) * | 2012-11-30 | 2015-10-07 | Leo Pharma A/S | A method of inhibiting the expression of il-22 in activated t-cells |
| TW201613934A (en) | 2014-06-23 | 2016-04-16 | Leo Pharma As | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
| JP6742348B2 (ja) | 2015-06-19 | 2020-08-19 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 第ｘｉａ因子阻害剤としてのジアミド大員環 |
| KR20180095888A (ko) * | 2015-12-18 | 2018-08-28 | 레오 파마 에이/에스 | 1,3-벤조디옥솔 복소환형 화합물의 제조 방법 |
| RU2762279C2 (ru) * | 2016-12-12 | 2021-12-17 | Юнион Терапьютикс А/С | Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы |
| JP6850887B2 (ja) * | 2016-12-12 | 2021-03-31 | レオ ファーマ アクティーゼルスカブ | 置換ピラゾロアゼピン−８−オンおよびそれらのホスホジエステラーゼ阻害剤としての使用 |
| CN110167944B (zh) * | 2016-12-12 | 2024-08-23 | 联合疗法公司 | 取代的吡唑并氮杂䓬-4-酮类及其作为磷酸二酯酶抑制剂的用途 |
| IL271399B (en) * | 2017-06-20 | 2022-07-01 | Leo Pharma As | Methods for the preparation of heterocyclic 3,1-benzodioxole compounds |
| TW201919682A (zh) | 2017-08-08 | 2019-06-01 | 西班牙商阿爾米雷爾有限公司 | 活化Ｎｒｆ２路徑的新穎化合物 |
| EP3724196B9 (en) | 2017-12-15 | 2023-03-22 | UNION therapeutics A/S | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9507297D0 (en) | 1995-04-07 | 1995-05-31 | Rh Ne Poulenc Rorer Limited | New composition of matter |
| DK0771794T3 (da) * | 1995-05-19 | 2006-09-11 | Kyowa Hakko Kogyo Kk | Oxygenholdige heterocykliske forbindelser |
| US6514996B2 (en) * | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
| IL126558A (en) | 1996-05-20 | 2002-07-25 | Darwin Discovery Ltd | Benzofuran carboxamides and pharmaceutical compositions containing them |
| TR199900429T2 (xx) * | 1996-08-28 | 1999-05-21 | The Procter & Gamble Company | Spirosiklik metaloproteaz inhibit�rleri. |
| WO1998022455A1 (fr) | 1996-11-19 | 1998-05-28 | Kyowa Hakko Kogyo Co., Ltd. | Composes heterocycliques d'oxygene |
| WO1999016768A1 (en) * | 1997-10-01 | 1999-04-08 | Kyowa Hakko Kogyo Co., Ltd. | Benzofuran derivatives |
| DE19907038C2 (de) | 1999-02-19 | 2003-04-10 | Schott Glas | Transluzente oder opake Glaskeramik mit Hochquarz-Mischkristallen als vorherrschender Kristallphase und deren Verwendung |
-
2008
- 2008-02-26 MY MYPI20093168A patent/MY150075A/en unknown
- 2008-02-26 SI SI200831224T patent/SI2114951T1/sl unknown
- 2008-02-26 BR BRPI0807749A patent/BRPI0807749B8/pt active IP Right Grant
- 2008-02-26 EP EP08706922.5A patent/EP2114951B9/en active Active
- 2008-02-26 PL PL08706922T patent/PL2114951T3/pl unknown
- 2008-02-26 MX MX2009009238A patent/MX2009009238A/es active IP Right Grant
- 2008-02-26 RS RS20140365A patent/RS53407B/en unknown
- 2008-02-26 US US12/528,649 patent/US8338431B2/en active Active
- 2008-02-26 DK DK08706922.5T patent/DK2114951T3/da active
- 2008-02-26 KR KR1020097018073A patent/KR101571654B1/ko active IP Right Grant
- 2008-02-26 CA CA2676933A patent/CA2676933C/en active Active
- 2008-02-26 WO PCT/DK2008/000080 patent/WO2008104175A2/en active Application Filing
- 2008-02-26 AU AU2008221121A patent/AU2008221121B2/en active Active
- 2008-02-26 ES ES08706922.5T patent/ES2478670T3/es active Active
- 2008-02-26 PT PT87069225T patent/PT2114951E/pt unknown
- 2008-02-26 RU RU2009135810/04A patent/RU2495043C2/ru active
- 2008-02-26 NZ NZ578804A patent/NZ578804A/en unknown
- 2008-02-26 JP JP2009551915A patent/JP5501770B2/ja active Active
-
2009
- 2009-07-30 IL IL200153A patent/IL200153A/en active IP Right Grant
-
2010
- 2010-04-07 HK HK10103418.6A patent/HK1138262A1/xx unknown
-
2014
- 2014-06-17 CY CY20141100437T patent/CY1115227T1/el unknown
- 2014-06-23 HR HRP20140585AT patent/HRP20140585T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2009135810A (ru) | 2011-04-10 |
| EP2114951B9 (en) | 2015-09-02 |
| RS53407B (en) | 2014-10-31 |
| PL2114951T3 (pl) | 2014-10-31 |
| KR101571654B1 (ko) | 2015-11-25 |
| MY150075A (en) | 2013-11-29 |
| ES2478670T3 (es) | 2014-07-22 |
| BRPI0807749B1 (pt) | 2021-01-05 |
| CY1115227T1 (el) | 2017-01-04 |
| HK1138262A1 (en) | 2010-08-20 |
| HRP20140585T1 (hr) | 2014-09-12 |
| US8338431B2 (en) | 2012-12-25 |
| RU2495043C2 (ru) | 2013-10-10 |
| EP2114951A2 (en) | 2009-11-11 |
| BRPI0807749B8 (pt) | 2022-09-06 |
| PT2114951E (pt) | 2014-07-17 |
| BRPI0807749A2 (pt) | 2014-06-17 |
| CA2676933A1 (en) | 2008-09-04 |
| WO2008104175A2 (en) | 2008-09-04 |
| IL200153A (en) | 2016-11-30 |
| EP2114951B1 (en) | 2014-04-09 |
| MX2009009238A (es) | 2009-09-08 |
| JP5501770B2 (ja) | 2014-05-28 |
| US20100099688A1 (en) | 2010-04-22 |
| AU2008221121B2 (en) | 2013-10-03 |
| NZ578804A (en) | 2012-04-27 |
| AU2008221121A1 (en) | 2008-09-04 |
| KR20090126252A (ko) | 2009-12-08 |
| WO2008104175A3 (en) | 2009-01-29 |
| CA2676933C (en) | 2015-09-29 |
| JP2010519332A (ja) | 2010-06-03 |
| DK2114951T3 (da) | 2014-06-23 |
| IL200153A0 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201000648D0 (en) | Phosphodiesterase 10 inhibitors | |
| IL200153A0 (en) | Novel phosphodiesterase inhibitors | |
| HK1176601A1 (zh) | 抑制劑 | |
| HRP20130698T1 (en) | Novel phenylpyrazinones as kinase inhibitors | |
| HRP20130787T1 (en) | Imidazopyridazinecarbonitriles useful as kinase inhibitors | |
| ZA201004942B (en) | Ptrrolopyrazine kinase inhibitors | |
| IL205205A0 (en) | Beta - lactamase inhibitors | |
| IL194424A0 (en) | 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors | |
| ZA201100898B (en) | Novel inhibitors | |
| HK1156611A1 (en) | Naphthyridininones as aurora kinase inhibitors aurora | |
| EP2379076A4 (en) | PHOSPHODIESTERASE HEMMER AND ITS USES | |
| ZA200905371B (en) | Novel phosphodiesterase Inhibitors | |
| ZA201102837B (en) | Phosphodiestarase inhibitors | |
| EP2177529A4 (en) | NEW DE-SECRETASE INHIBITOR | |
| EP2222662A4 (en) | INHIBITORS OF KYNURENINE AMINO TRANSFERASE | |
| ZA200908943B (en) | Pyrazolopyrimidinone kinase inhibitor | |
| IL197981A0 (en) | Kinase inhibitors | |
| GB0714941D0 (en) | Inhibitors | |
| GB0622367D0 (en) | Phosphodiesterase inhibitors | |
| GB0707632D0 (en) | Novel inhibitors | |
| GB0707499D0 (en) | Novel inhibitors | |
| GB0707498D0 (en) | Novel inhibitors | |
| GB0707497D0 (en) | Novel inhibitors | |
| GB0707495D0 (en) | Novel inhibitors | |
| GB0707493D0 (en) | Novel inhibitors |